Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Value Weighted Index Funds Fees 2024 reveal how expense structures shape long-term results. This quick intro explains what to compare and how to pick affordable options.
23,499 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
As XRP fluctuates in a tight range, traders and analysts scrutinize whether the price prediction: reach $100? is conc...
CrowdStrike is grabbing renewed attention on Wall Street after reporting record ARR growth and its first GAAP profit,...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
Two blue chips face opposite paths as rates stay high and consumer patterns shift. McDonald’s shows earnings growth w...
NVIDIA leads AI chips while MICRON powers AI memory. This in-depth comparison helps investors decide the better buy: ...
MARA Holdings sold roughly 15,133 BTC for $1.1 billion to buy back convertible notes and trim debt, a move that reduc...
Meta Platforms is pursuing a bold $9 trillion valuation by 2031 even after a blistering market setback. The plan hing...